Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-ranging CPO (ciclopirox) solution in seborrhoeic dermatitis of the scalp
2005-001371-35Phase 2Completed
- Sponsor
- Stiefel Laboratories
- Start
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ciclopirox in seborrheic dermatitis (SD) (4 arms), sponsored by Stiefel Laboratories. Primary endpoint: Change in area of seborrhoeic dermatitis. Started Apr 2005; status: completed.
02
Drugs
ciclopirox
03
Conditions
seborrheic dermatitis (SD)
Beyond the preview
Go deeper on 2005-001371-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001371-35.